Medpace and DCRI-Duke exceed expectations in Phase II/III Staff Characteristics

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, N.C. – April 26, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase II/III Service Providers (9th Edition), containing findings focused on service provider selection and evaluation. Kevin Olson, CEO, explains, “This report offers critical information for those … Continued

Pharma Industry Lacks Consensus On Key Attribute Of A Sponsor-CMO Relationship

VP of Market Research at Industry Standard Research Kate Hammeke discusses how greater diversity in selection criteria leads to a cloudy decision-making process because no specific criterion dominates the CMO selection decision.   To help Life Science Leader’s readers understand more about these industry peers, ISR asked participants in the research to prioritize a list … Continued